Abstract
Introductionand Importance: Severe COVID19 patients under anticoagulant therapy are at the risk of developing hematoma. Case presentationWe present case of 11 COVID19 who were presented with localized skin ecchymosis lesions in different areas of the body and retroperitoneal hematoma in the posterior wall of the abdomen and chest. Clinical discussionCases of hematoma with severe COVID19 patients under anticoagulant therapy are reported in several case studies, particularly in geriatric population with the previous history of blood and/or cardiac disorders. ConclusionThese patients should be carefully monitored for hematomas by skilled nurse and practitioner and timely treated and monitored. -
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
